Rare but Serious Side Effects: Difficulty breathing or swelling (indicative of an allergic reaction)
The significance of this therapeutic class extends beyond simple weight reduction
Monitoring includes regular glucose testing, IGF-1 levels, metabolic panels, insulin sensitivity markers, and clinical assessments
In December, Novo Nordisk filed for FDA approval of CagriSema, an injectable combination of GLP-1 and amylin analogues. As these therapies advance through the pipeline, they may complement or enhance current GLP1based strategies
Its a gentle, effective way to support your bodys natural detox pathwaysespecially if youre exposed to stress, pollution, or processed foods